Nanoparticle-based immunotherapeutic strategies to overcome cancer drug resistance: From biological barriers to artificial intelligence-driven design

Drug Resistance Updates 2026

View at publisher

Authors: Xiangyi Kong, Ran Cheng, Wenxiang Zhang, Ye Lu, Yonemori Kan, Yi Fang, Jidong Gao, Jing Wang, Kuo Chu Hwang

DOI: 10.1016/j.drup.2026.101392

Cited by: 1

References: 403

Fields of Study & Subjects

Nanoplatforms for cancer theranostics interferon and immune responses Cancer Immunotherapy and Biomarkers

References 403